MON2 and hyperlipidemia: In this context, increased numbers of Mon2 and Mon3 subtypes in hyperlipidemia has been associated with atherosclerosis development [40], and other studies have noted an enhancement in circulating CD16+ monocytes (Mon2 and Mon3) in CVD [41], which is possibly linked to disease outcome [42].